CorWave today touted 60-day study results from its preclinical study to evaluate its left ventricular assist device. The study concluded that the company’s LVAD has the ability to provide chronic circulatory support with outstanding hemocompatibility. “We were thrilled by the performance of the pump. This study bolsters the excellent hemocompatibility data from our previous trials, […]
CorWave raises $17m for next-gen LVAD program
CorWave said today that it has raised approximately $16.5 million (EU €14 million) to help support the Calypso R&D program it is running to develop its Neptune cardiac assistance pump into a left ventricular assistance device. The France-based company said the Calypso program is intended to encompass all the stages of development for the Neptune LVAD […]
CorWave wins $4m from French Innovation Challenge
CorWave said today it was awarded approximately $3.5 million from France’s Worldwide Innovation Challenge, financed by BpiFrance’s Invest for The Future Program. France-based CorWave said it received the funds to support continued development of its NovaPulse mini-invasive cardiac support pump designed to treat patients with chronic heart failure. The NovaPulse system utilizes undulating wave pumps […]
LVAD dev CorWave raises $17.1m in Series B
Circulatory support device developer CorWave said today it raised $17.1 million in a Series B round of financing to support its novel left ventricular assist device. The round was led by new investor Novo Seeds, joined by existing shareholders Sofinnova Partners, Bpifrance and Seventure and joined by new investor Ysios Capital. CorWave said it has […]
